-
Second DCIS Diagnoses May Not Be Related to Initial LesionDNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.
by Eric Fitzsimmons
-
Cracking the Code of Acute Myeloid LeukemiaTesting for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.
by Kendall K. Morgan
-
Forward Look
Comparing Antibody-Drug Conjugates for Metastatic Breast CancerResults favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
-
Forward Look
What’s Next?Artificial intelligence may help to classify colorectal polyps.
by Nancy Averett
-
Balancing Early-Stage Prostate Cancer DecisionsChoices about screening and treatment for early-stage prostate cancer are complex and largely personal.
by Kendall K. Morgan
-
When Cancer Is in the FamilyYou've inherited a genetic variant linked to cancer risk. Now what?
by Stephen Ornes
-
Survivor Profile
Strength in the PackWhile undergoing treatment for colon cancer, Trevor Maxwell started Man Up to Cancer, a support community for men.
by Jon Kelvey
-
Forward Look
CAR T Cells for Blood Cancer PatientsResearchers aim to minimize disease relapses by targeting multiple proteins.
by Erin O'Donnell
-
Get Involved
Doing Yoga in RecoveryA volunteer program brings yoga to cancer patients in the hospital.
by Bradley Jones
-
Q&A
The Certainty of UncertaintyAfter a stage IV cancer diagnosis, Kate Bowler publishes a second memoir that explores the precarious nature of her own mortality.
by Marci A. Landsmann
More than half of patients who participated in a program offering online second opinions were recommended a change to their treatment plan.
by Eric Fitzsimmons
Musical Toxicity an Effect of Cancer TreatmentStudy finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
Treatment Lags Behind Guidelines for Many Men With Prostate CancerGuidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
